Company: INMB
Filing Date: 2025-11-18
Form Type: 8-K
Source: 0001213900-25-112136
Chunk: 1

Company: Inmune Bio, Inc.
Filing Date: 2025-11-18
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

  Exhibit No.      Description                                                                  
         99.1      Press Release, dated November 18, 2025                                       
 ────────────────────────────────────────────────────────────────────────────────────────────────
          104      Cover Page Interactive Data File (embedded within the Inline XBRL document)  

SIGNATURES

Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                               INMUNE BIO INC.                               
  Date: November 18, 2025      By:                  /s/ David Moss           
                                                    David Moss               
                                                    Chief Executive Officer